Starting SPRAVATO®
Considerations for effective referrals for adult patients with TRD
Identify your adult patients who may be appropriate for SPRAVATO®, and follow the below steps for a possible referral:

TALK to your patient about SPRAVATO®1
Educate your patients on what SPRAVATO® does, the potential benefits and risks, and the need for visiting a certified SPRAVATO® treatment center. Also offer them a Medication Guide.

HELP your patient choose a certified SPRAVATO® treatment center
Coordinate care, make the referral, and consider scheduling your patient’s first appointment.

SHARE all relevant patient information with the certified SPRAVATO® treatment center
Be sure to provide your contact details as well as all relevant patient, clinical, and insurance information.
Read the Effective Referrals Guide to help support your patient’s treatment journey.
Locate a certified
SPRAVATO® treatment center
Once you’ve decided SPRAVATO® may be an option for your adult patients with TRD, help them locate a certified SPRAVATO® treatment center in one of 2 ways:

CALL JANSSEN CAREPATH
844-777-2828
Monday–Friday, 8:00 AM to 8:00 PM ET


Becoming a REMS-certified
SPRAVATO® treatment center
Learn more from physicians currently treating adult patients with TRD in operational certified treatment centers.
These healthcare providers have been compensated by Janssen Pharmaceuticals, Inc., for their participation in the video.
For practices interested in becoming a certified SPRAVATO® treatment center, consider the following:

• Treatment centers must comply with full SPRAVATO® REMS requirements. For full REMS requirements, visit SPRAVATOrems.com or call 855-382-6022

• SPRAVATO® is a Schedule III controlled substance
– Treatment center protocols should be followed for handling Schedule III products in accordance with federal, state, and local regulations

• SPRAVATO® treatment requires the ability and capacity for scheduling frequent appointments

• SPRAVATO® treatment requires staff and equipment to provide appropriate patient monitoring
1. SPRAVATO® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc. July 2020.